Even though Gangwal stands on thin ice if the powers entrusted in the shareholders' agreement are considered; Bhatia has much more to lose if this matter escalates further

The spectacular rise of a reticent man who has pushed his company to the top but still avoids media glare and limelight

Ajanta Pharma share price which stood at Rs 12.41 on October 30, 2009 has risen to Rs 1,020 during the period.

Weighed down by USFDA observations, share price of Aurobindo Pharma declined as much as 20.65 per cent to hit a 52-week low of Rs 450 on the BSE, after opening tad lower at Rs 560 against previous close level of Rs 567.15 on the BSE

As per the proposal, Glenmark Pharma plans to raise up to $200 million in Indian and/or international market through bonds, debentures or other debt securities in one or more tranches

Kemwell will take a minority stake in Stempeutics and invest up to Rs 95 crore based on certain milestones as well as establish a world class cGMP cell therapy manufacturing  facility  at  Kemwell's  facility  in  Bengaluru.

Zydus Cadila, India's fourth-largest drug company by revenue, is banking big on research of new drugs, even though others have bowed out. Zydus expects the new drug business to grow to Rs 3,500 crore in four-five years

As per the agreement, Glenmark will receive an upfront payment, licence fees and royalties for the non-exclusive sub-license rights from Torrent

Glenmark Pharma's shares opened 5 points down at Rs 495 after forming a gap down chart pattern at the opening bell, against the last close of Rs 500